(Q56897513)
Statements
Efficacy and safety of retreatment with ipilimumab in patients with pretreated advanced melanoma who progressed after initially achieving disease control (English)
0 references
15 April 2013
0 references
19
0 references
8
0 references
2232-9
0 references